Stockreport

Opus Genetics to Present at the J.P. Morgan 2026 Healthcare Conference

Opus Genetics, Inc.  (IRD) 
PDF RESEARCH TRIANGLE PARK, N.C., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutica [Read more]